Antiobesity interventions: options, evidence and value

Affiliations

¹ Department of Health Policy and Management, Columbia University Mailman School of Public Health, New York, New York, USA ebe2115@cumc.columbia.edu.
² Departments of General Medicine and Gastroenterology, Columbia University Irving Medical Center, New York, New York, USA.

Comment

Elena B Elkin et al. Gut. 2024.

. 2024 May 10;73(6):886-887.

doi: 10.1136/gutjnl-2023-330768.

¹ Department of Health Policy and Management, Columbia University Mailman School of Public Health, New York, New York, USA ebe2115@cumc.columbia.edu.
² Departments of General Medicine and Gastroenterology, Columbia University Irving Medical Center, New York, New York, USA.

No abstract available

Keywords: COST-EFFECTIVENESS; ENDOSCOPIC PROCEDURES; GASTRECTOMY; GLUCAGEN-LIKE PEPTIDES; OBESITY.

Conflict of interest statement

Competing interests: None declared.

Cost-effectiveness of endoscopic, surgical and pharmacological obesity therapies: a microsimulation and threshold analyses.
Saumoy M, Gandhi D, Buller S, Patel S, Schneider Y, Cote G, Kochman ML, Thiruvengadam NR, Sharaiha RZ. Saumoy M, et al. Gut. 2023 Nov 24;72(12):2250-2259. doi: 10.1136/gutjnl-2023-330437. Gut. 2023. PMID: 37524445